The latest updates from OTCMarkets | Not displaying properly? Click here
 
March 16, 2017
 
 
OTC Link ATS
 
OTC Link ATS Wins at Fund Technology and Wall Street Letter Awards
 

We’re proud to say OTC Markets’ OTC Link® ATS won “Best ATS Client Service” at the Fund Technology and Wall Street Letter Awards.

The annual awards recognize providers, including technology providers, data specialists and exchanges, catering to the institutional asset management community.

OTC Link ATS was rewarded for its work in providing superior client service to institutional traders who use our ATS to quote and trade message in 10,000 OTCQX, OTCQB and Pink securities.

 

Congratulations to the entire OTC Link ATS team!

 
 
 
Blue Sky Recognition - 21 States
 

Delaware now recognizes OTCQX and OTCQB for the purposes of its "Blue Sky Manual Exemption" for secondary trading, joining the 20 states that have already recognized our markets. Read more.

 
 
OTCQX Celebrates 10 Years
 

Launched in March 2007, the OTCQX Best Market was designed to provide reputable U.S. and international companies a cost-effective, less burdensome alternative to a stock exchange listing. Learn about how the market has grown in the past 10 years.

 
 
 
Community Spotlight
 

Stephen Nightingale
Director of Investor Relations

Britvic plc (OTCQX: BTVCY)

"We are investing in our GB infrastructure to support our future growth plans and we are bringing onstream some great new production lines that give us lower costs to produce, significantly improved pack flexibility as well as additional capacity to meet our customer needs. Outside of Europe we are investing in both Brazil and the USA to realise our international ambitions."

 

Read the full interview.

OTC Markets Group (OTCM): It has been about a year since we last spoke. How is business at Britvic?

Stephen Nightingale: Business is good. We had a strong 2016 with revenue and profit ahead of the previous year and our Q1 results this year saw revenue increase nearly 5% on 2016. Given the tough macro conditions and challenging retail conditions in our European markets we are pleased with our performance.

OTCM: What is Britvic's growth strategy for 2017?

Mr. Nightingale: Our outlook statement for 2017 has been cautious as we face rising cost inflation and a need to pass price increases onto retailers to protect our business as well as the added uncertainty of Brexit. We have some great innovation and marketing plans this year and we have won some great new business such as Subway in the UK. At the same time, we are investing in our GB infrastructure to support our future growth plans and we are bringing onstream some great new production lines that give us lower costs to produce, significantly improved pack flexibility as well as additional capacity to meet our customer needs. Outside of Europe we are investing in both Brazil and the USA to realise our international ambitions.

OTCM: Tell us about Britvic's U.S. IR strategy. What do you do to reach U.S. investors?

Mr. Nightingale: We come to the U.S. regularly both with senior management and our IR team. In addition to attending key conferences, we also roadshow across the U.S. and we enjoy great relations with the U.S. investor base. The ADR program and OTCQX market also provide a great platform to promote the Britvic investment case with investors.

OTCM: What else do you want U.S. investors to know about Britvic?

Mr. Nightingale: As well as being a hugely successful bottler for Pepsi in the UK and Ireland, we have a portfolio of market leading owned-brands. In the UK and Ireland, we are the leading supplier of low and no-sugar products and we have a pipeline of innovation to meet evolving consumer needs. With a new management in place since 2013, we have consistently delivered on meeting and beating market expectations. Whilst there are short-term headwinds at play we are very excited for the future prospects of the category and our ability to lead and win in the market.

Click to close.

 
 
 
Community Spotlight
 

Dr. Halden Shane
CEO and Chairman of the Board
TOMI Environmental Solutions, Inc. (OTCQX: TOMZ)

 

"In 2017, we are poised to grow externally in our national and international markets, and broaden our investor base. TOMI plans on developing and changing the disinfection/decontamination industry standards forever as we believe we offer the world’s most comprehensive deployable disinfection/ decontamination solution. TOMI has robust potential and we look forward to bringing in more investors to further our potential growth."

Read the full interview.

OTC Markets Group (OTCM): Tell us about TOMI.

Dr. Halden Shane: TOMI Environmental Solutions specializes in disinfection and decontamination solutions for companies whose facilities are at risk from infectious diseases. These facilities include hospitals, laboratories, and even schools. TOMI owns the technology and its related patents that was developed by DARPA and a U.S. defense company. TOMI sells and offers rapidly-deployable SteraMist™ Binary Ionization Technology® (BIT™) in both the United States and internationally with our SteraMist platform of products. TOMI also has custom build-in solutions of our SteraMist technology with our industry partners in containment, mitigation, and decontamination. Furthermore, the TOMI Service Network allows for our technology to be present in communities nationwide for routine and first responder service jobs. We are proud to offer solutions to disinfection/decontamination in the healthcare, pharmaceutical, laboratories, and commercial spaces.

OTCM: What were your major accomplishments in 2016?

Dr. Shane: In 2016, TOMI continued to work closely with our manufacturing partners to diversify our implementation in a variety of verticals, as well as evolving the capacity and applications of the SteraMist™ Binary Ionization Technology® (BIT™). In addressing our customers' needs, TOMI has developed numerous new designs of our SteraMist equipment to fit into numerous areas/spaces.

During 2016, TOMI filed four new patent applications with the U.S. Patent and Trademark Office to protect TOMI's groundbreaking SteraMist™ designs for decontamination and disinfection modules, chambers, carts, and other equipment.

TOMI is continuously developing custom fit build-in proposals for full rooms, pass-boxes, chambers, Bag-in/Bag-Out (BIBO), and other laboratory and bio-safety enclosures for our current and potential customers, as well as looking to invent new technologies to further our motto of “Innovating for a Safer World”.

TOMI continues to work closely with our licensed worldwide strategic customers and has supplied our technology to be developed for custom build-in applications for them. TOMI developed a rapid cycle decontamination unit in a custom enclosure for use by Type Solutions, SA, a laboratory and industrial equipment company located in Portugal. Similarly, TOMI technology is sold under license for customized build-in solutions for Telstar Group in Spain and AM Instruments Srl in Italy which the respective companies use within their pharmaceutical laboratory and cleanroom equipment which they manufacture. This provides their end users a decontamination/sterilization validation without damage to their clients' delicate equipment and fixed materials. These developments all result in a much quicker treatment time than competitive fogging decontamination/sterilization solutions.

TOMI in 2016 saw an improvement in our TOMI Service Network, welcoming 36 new providers for a total network of 58 providers using SteraMist BIT in their communities. In addition, TOMI continued to expand our end user client base, adding almost 50 new customers and expanding our global presence in Asia, EU and many other countries.

And of course, in September 2016 TOMI upgraded and began trading on the OTCQX Best Market under the symbol “TOMZ. ”

OTCM: How does TOMI differentiate itself from its competitors and what is your growth strategy for 2017?

Dr. Shane: We differentiate from our competitors in the way that any technology would ideally differentiate from a competitor by being faster, more efficient, using less caustic materials and being more environmentally friendly.

In 2017, we are approaching our growth strategy through several different angles:

  • Our Technology
  • Our Innovation
  • Our Partnerships

First, our Technology: We recently announced a continuation of our relationship with RG Group which has been our manufacturing partner for over two years now. We continue to work at improving our technology along with creating new applications platforms to implement our technology, which includes new ways to deliver disinfection/decontamination. This includes two prototypes which are currently in the works.

Our Innovation: Along with the prototypes which are currently being developed, we are continuing to test the efficacy of our BIT solution against harmful pathogens we find in the world's communities. This testing has led us to apply for an amended EPA registration which will open doors for additional services in new verticals, including food safety. Furthermore, we will continue to seek new methods of using our technology. Along with internal innovation, in 2017 we are expecting several papers to reflect efficacy in several areas which will show the diversity of the SteraMist product in many respective fields.

Our Partnerships: Soon, TOMI will announce partnerships in the world of disinfection/decontamination with like-minded companies and further expansion of our TOMI Service Network and facilities which will incorporate TOMI's SteraMist™ technology in their disinfection/decontamination plans.

OTCM: TOMI upgraded to OTCQX from the Pink market in September 2016. How are you planning to use OTCQX as part of your IR program?

Dr. Shane: In 2017, OTCQX will play a large role in our IR program as we look to the OTCQX Market for guidance in helping expand our investor base. We see OTCQX's growth as our own. OTCQX attracts high-tech and forward-thinking investors, and TOMI sees its technology in line with such thinking. Coupled with the marketing, support and interactive nature of OTCQX, TOMI understands and appreciates all these as advantages to its relationship with OTCQX.

OTCM: What else do you want investors to know about TOMI?

Dr. Shane: 2016 saw lots of investment and internal growth at TOMI. In 2017, we are poised to grow externally in our national and international markets, and broaden our investor base. TOMI plans on developing and changing the disinfection/decontamination industry standards forever as we believe we offer the world's most comprehensive deployable disinfection/ decontamination solution. TOMI has robust potential and we look forward to bringing in more investors to further our potential growth.

Click to close.

 
 
OTC Markets Blog
 
Understanding Blue Sky Laws
 

OTC Markets Blog: The OTC equity market operates within a unique, often complex regulatory environment. Companies, broker-dealers, investors and others comprising the OTC market must understand the impact of state “Blue Sky” laws. Read the full post.

 
 
Addressing the SEC White Paper on OTC Equities
 

OTC Markets Blog: The SEC paper on OTC equity securities draws a series of misinformed conclusions and does not address the improvements in transparency and technology made over the past several years. Read the full post.

 
 
Exegy is Now a Distributor of OTC Markets' Real-Time Level 1 and Level 2 Market Data
 

OTC Markets Group added Exegy Inc., a leading provider of managed services and technology for low-latency financial market data, as a new distributor of OTC Markets' real-time Level 1 and Level 2 market data in February.

With this agreement, Exegy's clients now have convenient access to real-time best bid and offering (BBO) pricing and full depth of book information for OTCQX, OTCQB and Pink market securities to aid in trading and investment decision-making. Read More.

 
 
Policy Enhancements for the Pink Market
 

As part of our ongoing effort to provide investors with access to quality information, OTC Markets Group periodically evaluates how our disclosure standards are utilized by the companies that trade on the OTC markets.

As a result, we recently refined our requirements for the Pink Limited Information category. Effective March 9th, any company that has not filed periodic financial reports within the prior six months will be labeled “Pink No Information”. 8-K/6-K filings with the SEC will no longer be sufficient to qualify for the Pink Limited Information category.

227 companies have been downgraded to Pink No Information as a direct result of this change to our standards.

 
 
Monthly Trade Summary - February 2017
 
 
Market Designations Number
of Securities*
Monthly
$ Volume
Monthly $ Volume
per Security
YTD $ Volume*
 
OTCQX 414 $3,165,077,658 $7,645,115 $6,972,755,490
OTCQB 977 $3,610,756,052 $3,695,758 $6,152,287,594
Pink 8,246 $12,109,222,699 $1,468,496 $25,182,124,380
Total 9,637 $18,885,056,410 $1,959,640 $38,307,167,464
 

*Data as of February 28, 2017

 
 
Events
 

OTCQX: Making It Painless To Go Public – Webinar (Archived Recording)

Sidoti & Company Spring 2017 Convention – New York, NY (March 29, 2017)

STANY’s 81st Annual Conference and Dinner – New York, NY (March 30, 2017)

NY Tech Day – New York, NY (April 18, 2017)

Planet MicroCap Showcase 2017 – Las Vegas, NV (April 26-28, 2017) 

Virtual Investor Conference for OTCQX International Companies – Webcast (May 11, 2017)

4th Annual OTCQX Senior Executive & Issuer‘s Forum – Vancouver, Canada (May 31, 2017)

FundIt 2017: The Crowdfunding, Compliance, Marketing and Fintech Conference – Washington D.C. (June 1-2, 2017)

The 7th Annual LD Micro Invitational Conference – Los Angeles, CA (June 6-7, 2017)

2017 Marcum Microcap Conference – New York, NY (June 15-16, 2017)

IR Magazine Awards Europe – London, U.K. (June 21, 2017)

Please contact events@otcmarkets.com for more information.

 
 
Investing in Banks - OTCQX Virtual Investor Conference
 

In case you missed the OTCQX Virtual Investor Conference on March 15th, the recorded webcasts are now available on-demand. View presentations from the senior executives of 13 OTCQX-traded U.S. banks where they discussed their business and investment stories and answered questions from investors. Also visit the virtual “exhibit hall” to view or download investor kits and annual reports. Archived Recording.

 
 
News
 

OTCQX Celebrates 10 Years as a Major Market AlternativeEquities (February 17, 2017)

OTCQX and OTCQB Blue Sky Recognition Expands to 20 Statespress release (February 22, 2017)

Wall Street‘s Nerds: The Most Powerful Trading ExecutivesInstitutional Investor Magazine (March 2017)

OTC Markets Group Adds Exegy as Distributor of Real-Time Level 1 and Level 2 Market DataTraders Magazine online (March 6, 2017)

OTCQX Best Market Celebrates 10th Anniversarypress release (March 6, 2017)

OTCQX: 10 years in the life of ‘a child of the internet age’ – IR Magazine online (March 8, 2017)

OTCQX And OTCQB Companies To Present At 2017 ROTH Conferencepress release (March 9, 2017)

Fund Technology and WSL Award Winners 2017Fund Technology (March 15, 2017)

 
 
New OTCQX and OTCQB Companies
 

Welcome to the companies that joined the OTCQX Best Market and the OTCQB Venture Market in February 2017.

The OTCQX Best Market
Advantage Lithium Corp. (OTCQX: AVLIF)
BBX Capital Corporation (OTCQX: BBXT, BBXTB)
Clean TeQ Holdings Ltd, Melbourne (OTCQX: CTEQF)
Mace Security International, Inc. (OTCQX: MACE)
Mogo Finance Technology Inc. (OTCQX: MOGOF)

The OTCQB Venture Market
Acura Pharmaceuticals, Inc. (OTCQB: ACUR)
All For One Media Corp. (OTCQB: AFOM)
American Patriot Oil & Gas Ltd. (OTCQB: ANPOF)
Argentina Lithium & Energy Corp (OTCQB: PNXLF)
Aurvista Gold Corp (OTCQB: ARVSF)
Bemax Inc. (OTCQB: BMXC)
Bingo Nation, Inc. (OTCQB: BLTO)
Blackrock Gold Corp (OTCQB: BKRRF)
Blue Sky Uranium Corp. (OTCQB: BKUCF)
CannaRoyalty Corp. (OTCQB: CNNRF)
Cardiff International, Inc. (OTCQB: CDIF)
CB Financial Corp. (OTCQB: CBFA)
Eco Science Solutions, Inc. (OTCQB: ESSI)
Emergent Capital, Inc. (OTCQB: EMGC)
Genoil Inc. (OTCQB: GNOLF)
Gripevine Inc. (OTCQB: GRPV)
Healthtalk Live Inc (OTCQB: HLTK)
Image Chain Group Limited, Inc. (OTCQB: ICGL)
Jackpot Digital Inc. (OTCQB: JPOTF)
Kootenay Zinc Corp (OTCQB: KTNNF)
Lexagene Hldgs Inc. (OTCQB: LXXGF)
Molori Energy Inc. (OTCQB: MOLOF)
Namaste Technologies Inc (OTCQB: NXTTF)
Nami Corp. (OTCQB: NINK)
Neutrisci Intl Inc (OTCQB: NRXCF)
Nouveau Monde Graphite Inc. (OTCQB: NMGRF)
Players Network (THE) (OTCQB: PNTV)
Prism Technologies Group, Inc. (OTCQB: PRZM)
Saint Jean Carbon Inc. (OTCQB: TORVF)
Sunset Island Group, Inc. (OTCQB: SIGO)
Transgenomic, Inc. (OTCQB: TBIO)
Vinergy Res Ltd. (OTCQB: VNNYF)
West Kirkland Mining Inc. (OTCQB: WKLDF)
Wike Corp (OTCQB: WKKE)

 
 
Graduates to an Exchange Listing
 

Congratulations to the following companies that graduated from the OTCQB Venture Market to an exchange listing in February 2017.

AUXILIO, Inc. (NYSE MKT: AUXO)
Sigma Labs, Inc. (NASDAQ: SGLB)